CA Stock MarketDetailed Quotes

VM Voyageur Pharmaceuticals Ltd

Watchlist
  • 0.070
  • +0.005+7.69%
15min DelayMarket Closed Dec 13 16:00 ET
10.34MMarket Cap-7.00P/E (TTM)

Voyageur Pharmaceuticals Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
174.80%359.13K
-9.59%561.9K
-11.97%328.95K
-23.15%1.35M
-59.98%229.24K
-69.38%130.69K
30.42%621.49K
51.08%373.69K
-14.46%1.75M
11.32%572.81K
Selling and administrative expenses
245.75%249.39K
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
-72.27%72.13K
24.70%410.84K
132.10%234.31K
-27.01%1.07M
12.71%374.35K
-General and administrative expense
245.75%249.39K
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
-72.27%72.13K
24.70%410.84K
132.10%234.31K
-27.01%1.07M
12.71%374.35K
Research and development costs
73.64%64.37K
-36.83%104.82K
-85.53%12.63K
-46.75%280.94K
-109.74%-9.37K
-73.75%37.07K
19.91%165.95K
-39.88%87.29K
6.25%527.56K
-39.00%96.15K
Depreciation amortization depletion
-28.02%393
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
-24.90%546
-24.90%546
-24.90%546
29.47%2.91K
-67.63%727
-Depreciation and amortization
-28.02%393
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
-24.90%546
-24.90%546
-24.90%546
29.47%2.91K
-67.63%727
Other operating expenses
114.77%44.98K
18.10%52.15K
-28.47%36.87K
-16.11%123.24K
-93.50%6.6K
-15.50%20.94K
455.85%44.16K
10,614.97%51.54K
90.26%146.91K
350.47%101.58K
Operating profit
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
23.15%-1.35M
59.98%-229.24K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.46%-1.75M
-11.32%-572.81K
Net non-operating interest income (expenses)
-4.48K
0
Non-operating interest expense
----
----
----
--4.48K
----
----
----
----
--0
----
Other net income (expenses)
-2,368.77%-48.61K
-1.97K
Special income (charges)
----
----
--0
-2,368.77%-48.61K
----
----
----
----
---1.97K
----
-Less:Impairment of capital assets
----
----
--0
--48.61K
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
----
----
----
----
----
---4.24K
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
---6.21K
----
Income before tax
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Income tax
Earnings from equity interest net of tax
Net income
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Net income continuous operations
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Noncontrolling interests
Net income attributable to the company
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
69.38%-130.69K
-30.42%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
Diluted earnings per share
-161.42%-0.0026
13.60%-0.004
17.92%-0.0025
50.00%-0.01
0
73.56%-0.001
-0.26%-0.0047
-24.60%-0.003
0.00%-0.02
-0.01
Basic earnings per share
-161.42%-0.0026
13.60%-0.004
17.92%-0.0025
50.00%-0.01
0
73.56%-0.001
-0.26%-0.0047
-24.60%-0.003
0.00%-0.02
-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 174.80%359.13K-9.59%561.9K-11.97%328.95K-23.15%1.35M-59.98%229.24K-69.38%130.69K30.42%621.49K51.08%373.69K-14.46%1.75M11.32%572.81K
Selling and administrative expenses 245.75%249.39K-1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K-72.27%72.13K24.70%410.84K132.10%234.31K-27.01%1.07M12.71%374.35K
-General and administrative expense 245.75%249.39K-1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K-72.27%72.13K24.70%410.84K132.10%234.31K-27.01%1.07M12.71%374.35K
Research and development costs 73.64%64.37K-36.83%104.82K-85.53%12.63K-46.75%280.94K-109.74%-9.37K-73.75%37.07K19.91%165.95K-39.88%87.29K6.25%527.56K-39.00%96.15K
Depreciation amortization depletion -28.02%393-28.02%393-28.02%393-24.86%2.19K-24.90%546-24.90%546-24.90%546-24.90%54629.47%2.91K-67.63%727
-Depreciation and amortization -28.02%393-28.02%393-28.02%393-24.86%2.19K-24.90%546-24.90%546-24.90%546-24.90%54629.47%2.91K-67.63%727
Other operating expenses 114.77%44.98K18.10%52.15K-28.47%36.87K-16.11%123.24K-93.50%6.6K-15.50%20.94K455.85%44.16K10,614.97%51.54K90.26%146.91K350.47%101.58K
Operating profit -174.80%-359.13K9.59%-561.9K11.97%-328.95K23.15%-1.35M59.98%-229.24K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.46%-1.75M-11.32%-572.81K
Net non-operating interest income (expenses) -4.48K0
Non-operating interest expense --------------4.48K------------------0----
Other net income (expenses) -2,368.77%-48.61K-1.97K
Special income (charges) ----------0-2,368.77%-48.61K-------------------1.97K----
-Less:Impairment of capital assets ----------0--48.61K------------------0----
-Less:Other special charges -----------------------------------4.24K----
-Gain on sale of property,plant,equipment --------------0-------------------6.21K----
Income before tax -174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Income tax
Earnings from equity interest net of tax
Net income -174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Net income continuous operations -174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Noncontrolling interests
Net income attributable to the company -174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K69.38%-130.69K-30.42%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K
Diluted earnings per share -161.42%-0.002613.60%-0.00417.92%-0.002550.00%-0.01073.56%-0.001-0.26%-0.0047-24.60%-0.0030.00%-0.02-0.01
Basic earnings per share -161.42%-0.002613.60%-0.00417.92%-0.002550.00%-0.01073.56%-0.001-0.26%-0.0047-24.60%-0.0030.00%-0.02-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.